BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

What’s New in ALS

Activity Snapshot

Activity Type: 
PowerPoint
Release Date: 
Tuesday, March 12, 2019
Sponsor Information: 

This program is supported by an independent educational grant from Mitsubishi Tanabe Pharma America, Inc.

Faculty

Dr. Robert L. Sufit
Northwestern University Feinberg School of Medicine
Dr. John M. Coleman
Northwestern University Feinberg School of Medicine
What’s New in ALS
Activity Overview: 

The MDA Medical Education team has partnered with Dr. Robert L. Sufit and Dr. John M. Coleman from the Northwestern University Feinberg School of Medicine to create a detailed presentation discussing the multiple aspects of ALS care. These slides will help physicians to learn more about the diagnosis process of ALS, the mechanism of disease, and how to proactively manage symptoms.